Article
Hyperhomocysteinemia, DNA methylation and vascular disease
1 Jan 2007
Abstract excerpt
Hyperhomocysteinemia (HHcy) has been established as a potent independent risk factor for cardiovascular disease (CVD) and the underlying mechanism is largely unknown. We were the first to propose that hypomethylation is the key biochemical mechanism by which homocysteine (Hcy) inhibits endothelial cell (EC) growth. We reported that clinically relevant concentrations of Hcy (10-50 micromol/L) exerts highly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
